Labetuzumab Biosimilar - Anti-CEACAM5 Antibody - BSA and Azide free
Description
Recombinant humanized monoclonal antibody to CEACAM5.
Applications
ELISA
Dilutions
ELISA: 1:5,000-10,000
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Isotype
IgG1
Conjugate
Unconjugated
Purification
Affinity chromatography.
Concentration
Reconstitution dependent.
Product Form
Lyophilized
Reconstitution
Reconstitute with distilled sterile water.
Formulation
Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%–8% Trehalose is added as a protectant before lyophilization.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
General Notes
Prior to reconstitution, centrifuge the vial at 5,000g for 3-5 minutes at room temperature. Reconstitute with appropriate volume of distilled sterile water to bring product to 1mg/ml concentration. After addition of distilled sterile water, mix by gentle tapping. Note: It is not recommended to vortex or vigorously pipette the sample.
ELISA plates were pre-coated with 2 µg/ml (100 µl/well) Recombinant Human CEACAM5 Protein (6xHis Tag) (A318342) which can bind Anti-CEACAM5 Humanized Antibody [Labetuzumab Biosimilar] - Azide free (A318921) in a linear range of 2.56-320 µg/ml.
Flow cytometry analysis with Anti-CEACAM5 Humanized Antibody [Labetuzumab Biosimilar] - Azide free (A318921) on Expi293 cells transfected with human CEACAM5 (blue histogram) or Expi293 transfected with irrelevant protein (red histogram).
Publishing research using Labetuzumab Biosimilar - Anti-CEACAM5 Antibody - BSA and Azide free (A318921)? Please let us know so that we can list the citation on this page.
Alternative products to Labetuzumab Biosimilar - Anti-CEACAM5 Antibody - BSA and Azide free (A318921)